Differential effects of two different routes of immunization on protection against gram-negative sepsis by a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine in a burned mouse model

被引:8
作者
Neely, AN
Bhattacharjee, AK
Babcock, GF
Holder, IA
Cross, AS
机构
[1] Univ Cincinnati, Coll Med, Shriners Hosp Children, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45229 USA
[3] Walter Reed Army Inst Res, Dept Bacterial Dis, Washington, DC USA
[4] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
来源
JOURNAL OF BURN CARE & REHABILITATION | 2002年 / 23卷 / 05期
关键词
D O I
10.1097/00004630-200209000-00006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Gram-negative sepsis causes morbidity and mortality in burned patients. To determine whether immunization with core endotoxin (lipopolysaccharide) via one of two routes could protect burned mice from septic death, mice were immunized either three times subcutaneously (SC) or one time intramuscularly (IM) then two times intraperitoneally (IP) with a core-lipopolysaccharide vaccine. Control mice were immunized with either saline or an irrelevant antigen. Postimmunization, mice were immunocompromised with a 15% TBSA flame burn and challenged subeschar with Klebsiella pneumoniae or Escherichia coli. Vaccine immunization improved the survival of both E. coli- and K. pnenmoniae- challenged mice when given SC but not when given IM, IP. Postimmunization, total immunoglobulin titers were elevated over preimmune titers, but titers in IM, IP-immunized mice were higher than those in SC-immunized mice. Both isotyping and flow cytometry studies indicated that sera from mice immunized via IM, IP opsonized better than sera from mice immunized via SC. Hence, this vaccine provided route-specific protection of burned mice against gram-negative sepsis; its mechanism of action was not solely dependent upon increased immunoglobulin titers or phagocytosis.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 34 条
  • [1] ABBAS AK, 1997, CELLULAR MOL IMMUNOL, P271
  • [2] Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit:: Antibiotic use as risk factor for colonization and infection
    Asensio, A
    Oliver, A
    González-Diego, P
    Baquero, F
    Pérez-Díaz, JC
    Ros, P
    Cobo, J
    Palacios, M
    Lasheras, D
    Canton, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) : 55 - 60
  • [3] BAKER NR, 1999, CLIN MICROBIOL INFEC, V5, pS40
  • [4] Dendritic cells as vectors for therapy
    Banchereau, J
    Schuler-Thurner, B
    Palucka, AK
    Schuler, G
    [J]. CELL, 2001, 106 (03) : 271 - 274
  • [5] AFFINITY-PURIFIED ESCHERICHIA-COLI J5 LIPOPOLYSACCHARIDE-SPECIFIC IGG PROTECTS NEUTROPENIC RATS AGAINST GRAM-NEGATIVE BACTERIAL SEPSIS
    BHATTACHARJEE, AK
    OPAL, SM
    PALARDY, JE
    DRABICK, JJ
    COLLINS, H
    TAYLOR, R
    COTTON, A
    CROSS, AS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) : 622 - 629
  • [6] A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis group B outer membrane protein produces protective antibodies against gram-negative bacteremia
    Bhattacharjee, AK
    Opal, SM
    Taylor, R
    Naso, R
    Semenuk, M
    Zollinger, WD
    Moran, EE
    Young, L
    Hammack, C
    Sadoff, JC
    Cross, AS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) : 1157 - 1163
  • [7] Chang PC, 1996, NEPHROL DIAL TRANSPL, V11, P191
  • [8] Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis
    Cross, AS
    Opal, SM
    Warren, HS
    Palardy, JE
    Glaser, K
    Parejo, NA
    Bhattacharjee, AK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07) : 1079 - 1086
  • [9] CROSS AS, 1994, J ENDOTOXIN RES, V1, P57
  • [10] CROSS AS, 2001, 41 ICAAC ABSTR, P27